To develop a modular platform for delivering RNA therapeutics as an alternative to lipid nanoparticle systems.
Key Findings:
The supramolecular polycations form 'supra-polyplex' nanoparticles with RNA through electrostatic interactions.
Particles were typically below 150 nm with low polydispersity.
Nanoparticles delivered mRNA with transfection efficiencies comparable to commercial reagents while maintaining high cellular viability.
The system is adaptable to multiple RNA classes, effectively delivering siRNA and self-amplifying RNA.
Interpretation:
This modular platform offers a flexible and scalable alternative for RNA delivery, potentially enhancing the effectiveness of RNA therapies and expediting vaccine development.
Limitations:
Further mechanistic studies are needed to understand the influence of supramolecular architecture on intracellular trafficking and RNA release.
Conclusion:
The platform could support faster development of RNA-based vaccines and expand treatment options for various diseases.
